Venturepharm

Company introduction: Venturepharm group is an Asia based, life science leader with principal activities in an most affordable world-class innovative full service plus model from venture capital, merchant banking, CRO, CMO, CSO, compound partnering to royalty sharing. Venturepharm engages in strategic licensing of therapeutic compound pipelines, and markets projects to China, an emerging global top five market. Two of the flagships from the group are public trade companies: -Venturepharm Lab (HK stock exchange 8225), China's largest full-service CRO - Commonwealth Biotechnologies, Inc (NASDAQ: Capital market “CBTE”), The group now operates Eight distinct business units with over 4500 employees worldwide: